Hereditary angioedema with normal C1Inh

Recurrent swelling manifests as sudden and temporary enlargement of various body parts, often affecting the extremities, face, and genitals. This occurs due to increased vascular permeability caused by bradykinin overproduction. Over time, the frequency and severity of these episodes may increase, leading to more frequent disruptions. Daily life can be significantly impacted, with patients needing to avoid known triggers and use medications like bradykinin receptor antagonists to manage symptoms.

Abdominal pain presents as severe, cramping pain often accompanied by nausea and vomiting, resulting from intestinal wall edema. The pain is caused by the accumulation of fluid in the bowel wall, leading to distension and reduced blood flow. Episodes can last from several hours to a few days, often leading to misdiagnosis as a surgical emergency. Management includes supportive care and medications to reduce bradykinin levels, improving quality of life.

Facial swelling occurs as a sudden, painless enlargement of facial tissues, particularly around the eyes and lips. This is due to increased permeability of blood vessels in the facial region, mediated by bradykinin. Swelling can progress rapidly, sometimes leading to airway obstruction if the throat is involved. Patients are advised to carry emergency medications and avoid known triggers to prevent life-threatening situations.

Laryngeal edema presents as swelling in the throat, causing difficulty breathing and a sensation of tightness. It results from fluid accumulation in the laryngeal tissues due to bradykinin-induced vascular permeability. This can progress quickly to a life-threatening situation, requiring immediate medical intervention. Patients are often prescribed emergency treatments like C1 inhibitor concentrates to prevent asphyxiation.

Peripheral edema is characterized by swelling in the hands, feet, and other extremities, often leading to discomfort and limited mobility. The underlying mechanism involves bradykinin-induced leakage of fluid from blood vessels into the surrounding tissues. Swelling episodes can last several days, affecting the patient's ability to perform daily tasks. Management includes avoiding triggers and using medications to control bradykinin levels.

Nausea and vomiting often accompany abdominal pain during an attack, resulting from bowel wall edema and reduced gastrointestinal motility. The biological mechanism involves fluid accumulation and inflammation in the gastrointestinal tract. These symptoms can lead to dehydration and electrolyte imbalances if not managed promptly. Patients are advised to maintain hydration and may require antiemetic medications during acute episodes.

Fatigue manifests as persistent tiredness and lack of energy, often following an acute swelling episode. It is believed to result from the body's inflammatory response and the physical toll of frequent attacks. Over time, chronic fatigue can lead to decreased productivity and quality of life. Management strategies include adequate rest, stress reduction, and addressing underlying inflammation with appropriate therapies.

Joint pain occurs as intermittent discomfort or aching in the joints, potentially linked to swelling episodes. The pain may be due to inflammation and fluid accumulation around the joints, although the exact mechanism is not fully understood. It can lead to reduced mobility and difficulty performing daily activities. Treatment may involve anti-inflammatory medications and physical therapy to maintain joint function.

Clinicians look for recurrent episodes of angioedema without urticaria, often affecting the face, extremities, gastrointestinal tract, and airway. A detailed family history is crucial, as hereditary patterns can guide suspicion towards hereditary angioedema. Physical examination may reveal swelling in affected areas during attacks, but is often normal between episodes. This step helps differentiate hereditary angioedema from allergic reactions and other forms of angioedema.

Ultrasound or CT scans are used to assess abdominal pain and swelling, particularly when gastrointestinal involvement is suspected. Imaging may reveal bowel wall edema or ascites, which supports the diagnosis of angioedema. These findings help confirm the diagnosis when correlated with clinical presentation and exclude other causes of abdominal pain such as appendicitis or bowel obstruction. Imaging is not definitive for hereditary angioedema but aids in ruling out other conditions.

Tests include measuring C1 inhibitor function and levels, C4 levels, and C1q levels. In hereditary angioedema with normal C1Inh, C1 inhibitor levels and function are normal, but C4 levels may be low during attacks. Abnormal results guide clinicians to suspect hereditary angioedema despite normal C1Inh levels. These tests help differentiate from other types of angioedema and guide further genetic testing.

Genetic testing focuses on sequencing the F12, PLG, and ANGPT1 genes, among others. Mutations in these genes confirm the diagnosis of hereditary angioedema with normal C1Inh. Results provide definitive confirmation of the condition and are crucial for family counseling regarding inheritance patterns. Genetic testing informs risk assessment for family members and guides long-term management strategies.